These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 6219617
21. Comparative in vitro activity of norfloxacin (MK-0366) and ten other oral antimicrobial agents against urinary bacterial isolates. Khan MY, Gruninger RP, Nelson SM, Klicker RE. Antimicrob Agents Chemother; 1982 May; 21(5):848-51. PubMed ID: 6213200 [Abstract] [Full Text] [Related]
22. Susceptibility of Bordetella pertussis to doxycycline, cinoxacin, nalidixic acid, norfloxacin, imipenem, mecillinam and rifampicin. Zackrisson G, Brorson JE, Björnegård B, Trollfors B. J Antimicrob Chemother; 1985 May; 15(5):629-32. PubMed ID: 2861190 [Abstract] [Full Text] [Related]
23. Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acid. Muytjens HL, van der Ros-van de Repe J, van Veldhuizen G. Antimicrob Agents Chemother; 1983 Aug; 24(2):302-4. PubMed ID: 6227281 [Abstract] [Full Text] [Related]
24. In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim. Chin NX, Neu HC. Antimicrob Agents Chemother; 1983 Nov; 24(5):754-63. PubMed ID: 6229216 [Abstract] [Full Text] [Related]
26. In vitro activity of enoxacin compared with norfloxacin and amikacin. van der Auwera P, de Moor G, Lacroix G, Mambour A, Rossion N, Schuyteneer F. Eur J Clin Microbiol; 1985 Feb; 4(1):55-8. PubMed ID: 3157568 [Abstract] [Full Text] [Related]
30. The comparative in-vitro activity of eight newer quinolones and nalidixic acid. King A, Phillips I. J Antimicrob Chemother; 1986 Nov; 18 Suppl D():1-20. PubMed ID: 3468100 [Abstract] [Full Text] [Related]
31. In vitro activity of ciprofloxacin (Bay o 9867). Fass RJ. Antimicrob Agents Chemother; 1983 Oct; 24(4):568-74. PubMed ID: 6228192 [Abstract] [Full Text] [Related]
32. The in-vitro activity of ciprofloxacin compared with that of norfloxacin and nalidixic acid. King A, Shannon K, Phillips I. J Antimicrob Chemother; 1984 Apr; 13(4):325-31. PubMed ID: 6233249 [Abstract] [Full Text] [Related]
33. Comparative in vitro activity of ciprofloxacin and five other quinoline derivatives against gram-negative isolates. Galante D, Pennucci C, Esposito S, Barba D. Drugs Exp Clin Res; 1985 Apr; 11(5):331-4. PubMed ID: 2941260 [Abstract] [Full Text] [Related]
34. Comparative activities of norfloxacin and fifteen other antipseudomonal agents against gentamicin-susceptible and -resistant Pseudomonas aeruginosa strains. Forward KR, Harding GK, Gray GJ, Urias BA, Ronald AR. Antimicrob Agents Chemother; 1983 Oct; 24(4):602-4. PubMed ID: 6228193 [Abstract] [Full Text] [Related]